BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shimizu M, Zaninotto G, Nagata K, Graham DY, Lauwers GY. Esophageal squamous cell carcinoma with special reference to its early stage. Best Practice & Research Clinical Gastroenterology 2013;27:171-86. [DOI: 10.1016/j.bpg.2013.03.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Park I, Kim Y, Yoon DH, Park SR, Kim HR, Kim JH, Jung H, Lee GH, Cho K, Kim S. Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience. Cancer Chemother Pharmacol 2014;74:995-1003. [DOI: 10.1007/s00280-014-2573-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zhu J, Ling Y, Xu Y, Lu M, Liu Y, Zhang C. Promoter hypermethylation of the RECK gene is associated with its low expression and poor survival of esophageal squamous cell carcinoma. Oncol Lett 2017;13:1911-8. [PMID: 28454343 DOI: 10.3892/ol.2017.5656] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Jain S, Dhingra S. Pathology of esophageal cancer and Barrett's esophagus. Ann Cardiothorac Surg. 2017;6:99-109. [PMID: 28446998 DOI: 10.21037/acs.2017.03.06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
4 Chen X, Wang W, Man H, Li P, Shan B. Increased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in mice. Oncol Lett 2017;13:2207-15. [PMID: 28454382 DOI: 10.3892/ol.2017.5688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Xu J, Jiang L, Kang D, Wu X, Xu M, Zhuo S, Zhu X, Lin J, Chen J. Multiphoton imaging of low grade, high grade intraepithelial neoplasia and intramucosal invasive cancer of esophagus. Laser Phys Lett 2017;14:045402. [DOI: 10.1088/1612-202x/aa5ff0] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Kvasha A, Khalifa M, Biswas S, Farraj M, Bramnik Z, Waksman I. Novel Transgastric Endoluminal Segmental Esophagectomy and Primary Anastomosis Technique: A Hybrid Transgastric Thoracoscopic Esophagectomy for the Treatment of High Grade Dysplasia and Early Esophageal Cancer in a Porcine Ex vivo Model. Front Surg 2021;8:676031. [PMID: 34277694 DOI: 10.3389/fsurg.2021.676031] [Reference Citation Analysis]
7 Wu D, Chen X, Xu Y, Wang H, Yu G, Jiang L, Hong Q, Duan S. Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma. Oncol Lett 2017;13:2745-50. [PMID: 28454461 DOI: 10.3892/ol.2017.5759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Y, Liu L, Wang Q, Guo L, Ye L, Zeng H, Zeng X, Yuan X, Li Y, Zhang Y, Zhou E, Hu B. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial. Endoscopy 2020;52:1066-74. [PMID: 32668474 DOI: 10.1055/a-1198-5232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li M, Cao RS, Hao B, Zhang HJ, Qiu HQ. MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4. Br J Cancer. 2014;111:2003-2013. [PMID: 25211657 DOI: 10.1038/bjc.2014.485] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
10 Appelman HD, Matejcic M, Parker MI, Riddell RH, Salemme M, Swanson PE, Villanacci V. Progression of esophageal dysplasia to cancer. Ann N Y Acad Sci. 2014;1325:96-107. [PMID: 25266019 DOI: 10.1111/nyas.12523] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Fassan M, Baffa R, Kiss A. Advanced precancerous lesions within the GI tract: the molecular background. Best Pract Res Clin Gastroenterol. 2013;27:159-169. [PMID: 23809238 DOI: 10.1016/j.bpg.2013.03.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
12 Chen X, Hu H, Liu J, Yang Y, Liu G, Ying X, Chen Y, Li B, Ye C, Wu D, Duan S. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma. Tumour Biol 2017;39:1010428317692230. [PMID: 28222662 DOI: 10.1177/1010428317692230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
13 Udagawa H. Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer. Ann Gastroenterol Surg 2020;4:324-30. [PMID: 32724875 DOI: 10.1002/ags3.12338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]